Chemistry:Rigerimod

From HandWiki
Revision as of 17:37, 23 October 2022 by Carolyn (talk | contribs) (update)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Rigerimod (IPP-201101, Lupuzor) is a polypeptide corresponding to the sequence 131-151 of the 70k snRNP protein with a serine phosphorylated in position 140.[1]

It gave encouraging results in a phase IIb trial for severe lupus.[1] Another phase IIb trial has started recruiting in the US.[2]

References

  1. ↑ 1.0 1.1 http://www.medicalnewstoday.com/articles/171853.php 23 Nov 2009
  2. ↑ "Cephalon, ImmuPharma license partner for Rigerimod (Lupuzor) initiates critical steps in its development program". Archived from the original on 2011-09-10. https://web.archive.org/web/20110910162346/http://www.biotech-intelligence.com/html/html/pool_7/77bad927fb067f0b63d6789a44ca53f7.html. Retrieved 2010-06-28. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Rigerimod&oldid=2206051"